Investigations into antidepressant drug response are generally based on observer ratings or
self-ratings. Therefore, the question arises as to the extent to which the respective results
reflect the expectations of raters and patients. To tackle this question, we conducted a study
of 43 hospitalized depressive patients to assess the time course of recovery at a dense
time points throughout the first two weeks of treatment. Our sample included 17 mild cases
(HAMD-17 baseline score <22), 13 moderately depressed patients (HAMD-17 baseline score 22-27),
and 13 severely depressed patients (HAMD-17 baseline score >27). All patients were treated
with antidepressants. The patients’ psychopathology was assessed on the basis of HAMD and AMDP
rating scales, and speech recordings were carried out for each patient immediately before the
psychiatric exploration. We performed six repeated assessments at a fixed time in the morning,
each Monday, Wednesday and Friday, plus a final assessment upon release from hospital.
The onset of improvement (20% sustained baseline score reduction) occurred in the great majority
of patients (79.1%) within the first 12 days of study, independently of the severity of
depression at baseline. Early improvement was highly predictive of later outcome, since 67.6%
of the patients showing improvement within the first 12 days were responders (50% sustained
baseline score reduction) by the end of the observation period. Inversely, 92% of the
responders at the end of the observation period exhibited an onset of improvement within the
first 12 days. Early improvement could not be attributed to a few HAMD items, because score
reductions were observed for virtually all items at early stages of treatment.
The analysis of the patients’ speaking behavior and voice sound characteristics yielded, in
62.8% of the cases, an essentially parallel development over time for the HAMD scores on the
one hand, and acoustic variables on the other (see Figures). The time course of
improvement thus appeared to have a strong biological component and was unlikely to be
attributable to the expectations of doctors and patients.
Moragrega I, Bridler R, Mohr C, Possenti M, Rochat D, Sanchez Parramon J, Stassen HH:
Monitoring Mental Health and the Effects of Therapeutic Interventions through Self-Assessment
Voice Analyses. Res Psychother. 2021, 24(3): 250-262
[
get the article]
Braun S, Annovazzi C, Botella C, Bridler B, Camussi E, Delfino JP, Mohr C, Moragrega I, Papagno C,
Pisoni A, Soler C, Seifritz E, Stassen HH: Assessing Chronic Stress, Coping Skills and Mood Disorders
through Speech Analysis. A Self-Assessment "Voice App" for Laptops, Tablets, and Smartphones.
Psychopathology 2016; 49(6): 406-419
[
get the article]
Braun S, Botella C, Bridler R, Chmetz F, Delfino JP, Herzig D, Kluckner VJ, Mohr C, Moragrega I, Schrag Y,
Seifritz E, Soler C, Stassen HH: Affective State and Voice: Cross-Cultural Assessment of Speaking Behavior and
Voice Sound Characteristics. A Normative Multi-Center Study of 577+36 Healthy Subjects. Psychopathology 2014;
47(5): 327-340
Stassen HH, Delfino JP, Kluckner VJ, Lott P, Mohr C: Vulnerabilität und psychische Erkrankung. Swiss Archives
of Neurology and Psychiatry 2014; 165(5): 152-157
Stassen HH, Anghelescu IG, Angst J, Böker H, Lötscher K, Rujescu D, Szegedi A, Scharfetter C.
Predicting Response to Psychopharmacological Treatment. Survey of Recent Results. Pharmacopsychiatry 2011; 44: 263-272
Stassen HH, Angst J, Hell D, Scharfetter C, Szegedi A: Is there a common resilience mechanism
underlying antidepressant drug response? Evidence from 2848 patients. J Clin Psychiatry 2007;
68(8): 1195-1205
Stassen HH: Veränderungen der Sprechmotorik. In: T.Jahn (ed) Bewegungsstörungen bei psychischen
Erkrankungen. Springer Heidelberg 2004; pp. 107-125
Lott PR, Guggenbühl S, Schneeberger A, Pulver AE, Stassen HH: Linguistic analysis of the speech
output of schizophrenic, bipolar, and depressive patients. Psychopathology 2002; 35(4): 220-227
Stassen HH, Angst J: Wirkung und Wirkungseintritt in der Antidepressiva-Behandlung. In: Böker H and
Hell D (eds) Therapie der affektiven Störungen. Stuttgart und New York 2002; Schattauer 141-165
Püschel J, Stassen HH, Bomben G, Scharfetter C and Hell D: Speaking behavior and voice sound
characteristics in acute schizophrenia. J. Psychiatric Research 1998; 32: 89-97
Stassen HH, Kuny S, Hell D: The speech analysis approach to determining onset of
improvement under antidepressants. Eur. Neuropsychopharmacology 1998; 8(4): 303-310
Kuny S, Stassen HH, Hell D: Kognitive Beeinträchtigungen in der Depression.
Schweiz Arch Neurol Psychiatrie 1997; 150,3: 18-25
Stassen HH, Albers M, Püschel J, Scharfetter C, Tewesmeier M, Woggon B: Speaking
behavior and voice sound characteristics associated with negative schizophrenia. J Psychiat Res. 1995; 29: 277-296
Stassen HH: Affekt und Sprache. Stimm- und Sprachanalysen bei Gesunden, depressiven und
schizophrenen Patienten. Monographien aus dem Gesamtgebiete der Psychiatrie, Bd. 79. 1995; Berlin, Heidelberg: Springer
Kuny S, Stassen HH: Speaking behavior and voice sound characteristics in depressive patients
during recovery. J Psychiat Res. 1993; 27: 289-307
Kraepelin, E: Manic Depressive Insanity and Paranoia (trans. By M. Barclay). Edinburgh, UK: Livingstone 1921